approval
saveBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE) — FDA approval
community read0 votes
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approvalBETAMETHASONE DIPROPIONATE: BETAMETHASONE DIPROPIONATE — FDA approvalJan 26, 2026
- approvalFLUOXETINE HYDROCHLORIDE: FLUOXETINE HYDROCHLORIDE — FDA approvalJan 15, 2026
- approvalFLUOXETINE HYDROCHLORIDE: FLUOXETINE HYDROCHLORIDE — FDA approvalJan 15, 2026
- approvalmycophenolate sodium DR: MYCOPHENOLATE SODIUM — FDA approvalJan 14, 2026
- approvalMYCOPHENOLATE MOFETIL: MYCOPHENOLATE MOFETIL — FDA approvalJan 14, 2026
- approvalMYCOPHENOLATE MOFETIL: MYCOPHENOLATE MOFETIL — FDA approvalJan 14, 2026
🐶 often sniffed alongside
top 8- drugBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE12 co-mentions · 6 sources
- tagApproval10 co-mentions · 3 sources
- drugALDACTAZIDE6 co-mentions · 4 sources
- tagSmall Molecule5 co-mentions · 3 sources
- companyGlenmark Pharmaceuticals Ltd3 co-mentions · 1 sources
- tagRecall3 co-mentions · 2 sources
- companyAurobindo Pharma Ltd2 co-mentions · 1 sources
- companyUnichem Pharmaceuticals (USA) Inc1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that